High neutralizing antibody titer in intensive care unit patients with COVID-19Li Liu, Zhiwei Chen, Kelvin Kai‐Wang To et al.|Emerging Microbes & Infections|2020Cited by 150
SARS-CoV-2 shedding and seroconversion among passengers quarantined after disembarking a cruise ship: a case seriesIvan Fan-Ngai Hung, Kwok-Yung Yuen, Sally Sau-Man Leung et al.|The Lancet Infectious Diseases|2020Cited by 131
Seroprevalence of SARS-CoV-2 in Hong Kong and in residents evacuated from Hubei province, China: a multicohort studyKelvin Kai‐Wang To, Kwok‐Yung Yuen, Vincent Chi‐Chung Cheng et al.|The Lancet Microbe|2020Cited by 102
Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant-Associated Receptor Binding Domain (RBD) Mutations on the Susceptibility to Serum Antibodies Elicited by Coronavirus Disease 2019 (COVID-19) Infection or VaccinationLin‐Lei Chen, Kelvin Kai‐Wang To, Lu Lu et al.|Clinical Infectious Diseases|2021Cited by 51
Boosting of serum neutralizing activity against the Omicron variant among recovered COVID-19 patients by BNT162b2 and CoronaVac vaccinesLu Lu, Kelvin Kai‐Wang To, Lin‐Lei Chen et al.|EBioMedicine|2022Cited by 30